FDA Inspection
Apitoria Pharma Private LimitedApitoria Pharma Private Limited – FDA Inspection, Feb 9, 2019
Record Details
This FDA Inspection record concerns Apitoria Pharma Private Limited, with an inspection on February 9, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Bapu R. Gaddam (Issuing Officer)
- Dipesh K. Shah
- Jose M. Cayuela (FDA Associated Person)
View Company Profile
ID · 20409a75-84a1-4092-aed4-c80b1ba09449
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1082414
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Apitoria Pharma Private Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 11, 2026 | Not classified | Office of Inspections and Investigations | |
| August 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 30, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apitoria Pharma Private Limited
- FDA Inspection 1342322 - 2026-09-11
- FDA Inspection 1178447 - 2022-08-02
- FDA Inspection 1005706 - 2017-02-21
- FDA Inspection 927750 - 2015-04-30
- FDA Inspection 790022 - 2012-06-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.